CWAN insider schedules NYSE sale of 11,275 common shares

Rhea-AI Filing Summary

Clearwater Analytics (CWAN) has a Form 144 notice for the potential sale of 11,275 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $217,043.75. The filing shows that Clearwater Analytics had 288,154,032 shares outstanding of common stock at the time referenced.

The securities to be sold come from an exercise of stock options for 6,275 shares on 11/17/2025, paid in cash, and from 5,000 restricted stock units acquired on 01/01/2024. The notice also lists recent sales over the past three months under a Rule 10b5-1 sales plan and direct sales by the same insider.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	11275	217043.75	288154032	11/17/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/17/2025	Exercise of Stock Options	Issuer			6275	11/17/2025	Cash
Common	01/01/2024	Restricted Stock Units	Issuer			5000	01/01/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales Plan for JAMES COX 777 W. Main Street, Suite 900 Boise ID 83702	Common	10/15/2025	11275	202677.50
JAMES COX 777 W. Main Street, Suite 900 Boise ID 83702	Common	09/30/2025	5919	104631.35
10b5-1 Sales Plan for JAMES COX 777 W. Main Street, Suite 900 Boise ID 83702	Common	09/15/2025	11275	219937.25

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the CWAN Form 144 filing disclose?

The Form 144 for CWAN discloses a planned sale of 11,275 shares of Clearwater Analytics common stock, with an aggregate market value of $217,043.75, to be sold through Morgan Stanley Smith Barney LLC on the NYSE.

How many Clearwater Analytics (CWAN) shares are outstanding in this filing?

The filing states that Clearwater Analytics had 288,154,032 shares outstanding of common stock at the time referenced, which is a baseline figure separate from the shares covered by this notice.

How were the CWAN shares in this Form 144 acquired?

The shares to be sold include 6,275 shares acquired on 11/17/2025 through an exercise of stock options for cash and 5,000 shares acquired as restricted stock units on 01/01/2024.

What recent CWAN insider sales are described in the Form 144?

The filing lists sales of Clearwater Analytics common stock over the past three months, including 11,275 shares sold on 10/15/2025 for $202,677.50, 5,919 shares on 09/30/2025 for $104,631.35, and 11,275 shares on 09/15/2025 for $219,937.25.

Which broker is handling the CWAN Form 144 share sale?

The planned sale of 11,275 shares of Clearwater Analytics common stock is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services at 1 New York Plaza, New York.

Is the CWAN Form 144 sale tied to a Rule 10b5-1 plan?

The filing references a 10b5-1 sales plan for the insider and includes sales under that plan in the past three months, alongside direct sales by the same person.